Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iBio (IBIO) Assets (2016 - 2025)

Historic Assets for iBio (IBIO) over the last 17 years, with Q4 2025 value amounting to $64.4 million.

  • iBio's Assets rose 19678.3% to $64.4 million in Q4 2025 from the same period last year, while for Dec 2025 it was $64.4 million, marking a year-over-year increase of 19678.3%. This contributed to the annual value of $23.2 million for FY2025, which is 1931.16% down from last year.
  • Latest data reveals that iBio reported Assets of $64.4 million as of Q4 2025, which was up 19678.3% from $64.2 million recorded in Q3 2025.
  • iBio's Assets' 5-year high stood at $147.0 million during Q2 2021, with a 5-year trough of $19.1 million in Q1 2025.
  • Its 5-year average for Assets is $68.2 million, with a median of $51.0 million in 2022.
  • In the last 5 years, iBio's Assets surged by 23798.44% in 2021 and then tumbled by 6191.13% in 2025.
  • iBio's Assets (Quarter) stood at $126.4 million in 2021, then crashed by 59.03% to $51.8 million in 2022, then crashed by 34.32% to $34.0 million in 2023, then tumbled by 36.23% to $21.7 million in 2024, then skyrocketed by 196.78% to $64.4 million in 2025.
  • Its Assets stands at $64.4 million for Q4 2025, versus $64.2 million for Q3 2025 and $23.2 million for Q2 2025.